Ann: Cortical Dynamics - Ethics Approval for BAR , page-9

re: Ann: Cortical Dynamics - Ethics Approval ... I am sure that if you still hold your Cortical and MDS share entitlement certificates (or whatever they were called), then there is no way DB could ever make you cough up more money just to get those shares if / when the two companies list...

I sent an email to Deborah Ambrosini many months ago and asked about Cortical and MDS only to be told that they were progressing toward commercialisation and listing. She also said more market announcements would be coming... when though?

I will hold both Cortical and MDS (hopefully), and I recall that the BPH share price went up as high as 40c on news of the cancer drug back in 2009 when MDS was spun off... This could be very exciting for future MDS holders IF it is progressing and not flopped already. Last we heard, the drug was going into trials (animal?) and nothing since then. Did it fail perhaps?

I cant understand why DB hasnt flogged MDS to the market for more money unless it has flopped. Or maybe he is keeping it in reserve for PEP11 Mark 2 so he can make another "exclusive offer" for investment in Advent???

The only thing that makes me feel a little confidence in Cortical and MDS is that their products are research and development projects of major institutions like Swinburne University and RMIT. Surely they wont allow their life's works to perish under DB's yoke?

Perhaps someone needs to pick up the phone, or send an email and ask the important questions, like what the hell is going on with our companies. BPH is gone as far as I am concerned ... I dont know what happened with the other biotech projects of BPH when it became an energy company, but they should at least be getting Cortical and MDS going...

Thanks for reading my whinge. I wonder if we will qualify for the Guiness Book of Records for the longest waiting shareholders...